摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(hydroxymethyl)-5-methyl-phenol | 606488-95-3

中文名称
——
中文别名
——
英文名称
3-(hydroxymethyl)-5-methyl-phenol
英文别名
3-(hydroxymethyl)-5-methylphenol
3-(hydroxymethyl)-5-methyl-phenol化学式
CAS
606488-95-3
化学式
C8H10O2
mdl
——
分子量
138.166
InChiKey
SDJQWNMVKBEBSJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.1
  • 重原子数:
    10
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    40.5
  • 氢给体数:
    2
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2907299090
  • 危险性防范说明:
    P261,P264,P270,P271,P280,P301+P312,P302+P352,P304+P340,P330,P363,P501
  • 危险性描述:
    H302,H312,H332

SDS

SDS:3c25ccc1bac5eafdcadba1ac1a547a4b
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-(hydroxymethyl)-5-methyl-phenol吡啶4-二甲氨基吡啶铁粉potassium carbonate溶剂黄146 、 lithium hydroxide 作用下, 以 四氢呋喃N,N-二甲基甲酰胺 为溶剂, 反应 30.67h, 生成
    参考文献:
    名称:
    化合物及其用途
    摘要:
    本发明公开了化合物及其用途,其中,该化合物为式(I)所示化合物或者式(I)所示的化合物的立体异构体、药学可接受的盐、溶剂合物或前药,本发明的化合物能够通过效应RRM2抑制肿瘤细胞增殖,并抑制肿瘤干细胞的再生,从而能够有效用于制备预防或治疗增殖性疾病的药物,尤其是抗肿瘤的药物。
    公开号:
    CN105693634B
  • 作为产物:
    描述:
    3-羟基-5-甲基苯甲酸甲醇 、 sodium tetrahydroborate 、 三乙胺 、 sodium hydroxide 作用下, 以 乙醇二氯甲烷 为溶剂, 反应 2.0h, 生成 3-(hydroxymethyl)-5-methyl-phenol
    参考文献:
    名称:
    [EN] AMIDE COMPOUNDS, COMPOSITIONS AND APPLICATIONS THEREOF
    [FR] COMPOSÉS AMIDES, COMPOSITIONS ET APPLICATIONS DE CEUX-CI
    摘要:
    本公开涉及替代酰胺化合物,这些化合物是脂肪酸酰胺水解酶(FAAH)的抑制剂,包括它们的立体异构体、互变异构体、前药、多型体、溶剂合物、药用盐以及含有它们的药物组合物。这些化合物在治疗、预防、预防、管理或辅助治疗与脂肪酸酰胺水解酶(FAAH)抑制相关的所有医疗状况中非常有用,例如疼痛,包括急性和术后疼痛,慢性疼痛,癌症疼痛,癌症化疗引起的疼痛,神经痛,伤害性疼痛,炎症性疼痛,背部疼痛,疾病引起的疼痛,如糖尿病性神经病变,神经病毒性疾病,包括人类免疫缺陷病毒(HIV),带状疱疹,如带状疱疹后神经痛;多发性神经病,神经毒性,机械神经损伤,腕管综合症,类似多发性硬化的免疫机制;睡眠障碍,焦虑和抑郁症,炎症性疾病,体重和进食障碍,帕金森病,成瘾,痉挛,高血压或其他疾病。该公开还涉及酰胺化合物的制备过程。公式(1)。本公开还涉及制备这类化合物的方法,以及含有它们的药物组合物。
    公开号:
    WO2013042139A1
点击查看最新优质反应信息

文献信息

  • Cancerous Cell Growth Inhibiting Compounds
    申请人:WISYS TECHNOLOGY FOUNDATION, INC.
    公开号:US20170342047A1
    公开(公告)日:2017-11-30
    The present invention provides a compound of Formula I, II or III or a salt or prodrug or derivative thereof that is useful for skin-whitening by inhibiting melanin formation and removing existing melanin and the inhibition of melanoma growth and/or the removal of existing melanoma cells.
    本发明提供了一种化合物I、II或III或其盐或前药或衍生物,通过抑制黑色素形成和去除现有黑色素以及抑制黑色素瘤生长和/或去除现有黑色素瘤细胞,在美白皮肤方面具有用处。
  • [EN] AMIDE COMPOUNDS, COMPOSITIONS AND APPLICATIONS THEREOF<br/>[FR] COMPOSÉS AMIDES, COMPOSITIONS ET APPLICATIONS DE CEUX-CI
    申请人:ADVINUS THERAPEUTICS LTD
    公开号:WO2013042139A1
    公开(公告)日:2013-03-28
    The present disclosure relates to substituted amide compounds that are inhibitors of Fatty Acid Amide Hydrolase (FAAH), their stereoisomers, tautomers, prodrugs, polymorphs, solvates, pharmaceutically acceptable salts, and pharmaceutical compositions containing them. These compounds are useful in the treatment, prevention, prophylaxis, management, or adjunct treatment of all medical conditions related to inhibition of Fatty Acid Amide Hydrolase (FAAH), such as pain including acute and post operative pain, chronic pain, cancer pain, cancer chemotherapy induced pain, neuropathic pain, nociceptive pain, inflammatory pain, back pain, pain due to disease of various origin such as: diabetic neuropathy, neurotropic viral disease including human immunodeficient virus (HIV), herpes zoster such as post herpetic neuralgia; polyneuropathy, neurotoxicity, mechanical nerve injury, carpal tunnel syndrome, immunologic mechanisms like multiple sclerosis; sleep disorders, anxiety and depression disorders, inflammatory disorders, weight and eating disorders, Parkinson's disease, addiction, spasticity, hypertension or other disorders. The disclosure also relates to the process of preparation of the amide compounds. Formula (1). The present disclosure also relates to methods for the preparation of such compounds, and to pharmaceutical compositions containing them.
    本公开涉及替代酰胺化合物,这些化合物是脂肪酸酰胺水解酶(FAAH)的抑制剂,包括它们的立体异构体、互变异构体、前药、多型体、溶剂合物、药用盐以及含有它们的药物组合物。这些化合物在治疗、预防、预防、管理或辅助治疗与脂肪酸酰胺水解酶(FAAH)抑制相关的所有医疗状况中非常有用,例如疼痛,包括急性和术后疼痛,慢性疼痛,癌症疼痛,癌症化疗引起的疼痛,神经痛,伤害性疼痛,炎症性疼痛,背部疼痛,疾病引起的疼痛,如糖尿病性神经病变,神经病毒性疾病,包括人类免疫缺陷病毒(HIV),带状疱疹,如带状疱疹后神经痛;多发性神经病,神经毒性,机械神经损伤,腕管综合症,类似多发性硬化的免疫机制;睡眠障碍,焦虑和抑郁症,炎症性疾病,体重和进食障碍,帕金森病,成瘾,痉挛,高血压或其他疾病。该公开还涉及酰胺化合物的制备过程。公式(1)。本公开还涉及制备这类化合物的方法,以及含有它们的药物组合物。
  • AMIDE COMPOUNDS, COMPOSITIONS AND APPLICATIONS THEREOF
    申请人:ADVINUS THERAPEUTICS LIMITED
    公开号:US20150065464A1
    公开(公告)日:2015-03-05
    The present disclosure relates to substituted amide compounds that are inhibitors of Fatty Acid Amide Hydrolase (FAAH), their stereoisomers, tautomers, prodrugs, polymorphs, solvates, pharmaceutically acceptable salts, and pharmaceutical compositions containing them. These compounds are useful in the treatment, prevention, prophylaxis, management, or adjunct treatment of all medical conditions related to inhibition of Fatty Acid Amide Hydrolase (FAAH), such as pain including acute and post operative pain, chronic pain, cancer pain, cancer chemotherapy induced pain, neuropathic pain, nociceptive pain, inflammatory pain, back pain, pain due to disease of various origin such as: diabetic neuropathy, neurotropic viral disease including human immunodeficient virus (HIV), herpes zoster such as post herpetic neuralgia; polyneuropathy, neurotoxicity, mechanical nerve injury, carpal tunnel syndrome, immunologic mechanisms like multiple sclerosis; sleep disorders, anxiety and depression disorders, inflammatory disorders, weight and eating disorders, Parkinson's disease, addiction, spasticity, hypertension or other disorders. The disclosure also relates to the process of preparation of the amide compounds. The present disclosure also relates to methods for the preparation of such compounds, and to pharmaceutical compositions containing them.
    本公开涉及替代酰胺化合物,它们是脂肪酸酰胺水解酶(FAAH)的抑制剂,包括它们的立体异构体、互变异构体、前药、多型体、溶剂合物、药用可接受盐以及含有它们的药物组合物。这些化合物在治疗、预防、预防、管理或辅助治疗与脂肪酸酰胺水解酶(FAAH)抑制相关的所有医疗状况中非常有用,如疼痛,包括急性和术后疼痛,慢性疼痛,癌症疼痛,癌症化疗引起的疼痛,神经痛,伤害性疼痛,炎症性疼痛,背部疼痛,疾病引起的疼痛,如糖尿病性神经病变,神经病毒性疾病,包括人类免疫缺陷病毒(HIV),带状疱疹,如带状疱疹后神经痛;多发性神经病,神经毒性,机械神经损伤,腕管综合症,免疫机制如多发性硬化症;睡眠障碍,焦虑和抑郁症,炎症性疾病,体重和进食障碍,帕金森病,成瘾,痉挛,高血压或其他疾病。本公开还涉及酰胺化合物的制备过程。本公开还涉及制备这类化合物的方法,以及含有它们的药物组合物。
  • Invertible amphiphilic polymers
    申请人:Thayumanavan Sankaran
    公开号:US20070293669A1
    公开(公告)日:2007-12-20
    Amphiphilic monomeric compounds and corresponding homopolymers and copolymers capable of assembly and invertible configuration in introduction to and change in fluid medium.
    具有两性单体化合物及相应的同聚物和共聚物能够在流体介质中进行组装和可逆配置。
  • 1H-Indole-2-Carboxylic Acid Derivatives Useful As PPAR Modulators
    申请人:Oplinger Jeffrey Alan
    公开号:US20100240642A1
    公开(公告)日:2010-09-23
    The present invention relates to certain indole derivatives that are modulators of PPARγ, to processes for their preparation, to pharmaceutical compositions containing them and to their use in medicine.
    本发明涉及某些吲哚衍生物,它们是PPARγ的调节剂,涉及它们的制备过程,包含它们的制药组合物以及它们在医学上的用途。
查看更多